Life or Debt: The Cost of Breakthrough Therapies

We're living through a golden age of medical breakthroughs from gene therapies that can cure inherited blindness, CAR-T treatments that eliminate blood cancers, and precision medicines that turn terminal diagnoses into manageable conditions. But these life-altering breakthroughs come with costs , including jaw-dropping price tags and unintended consequences for overall health. From $2.8 million gene therapies to $700,000 cancer treatments, the pharmaceutical industry has created a paradox where the most innovative medicines are financially accessible to the fewest patients. And patients face challenges beyond financial accessibility. These breakthrough treatments won't be indicated for all patients with a given condition. How do we improve the healthcare ecosystem holistically to both optimize access to breakthrough therapies and optimize outcomes for each patient- so no patient is left. Can we develop a system that doesn't force patients to make impossible choices between life or debt?